Literature DB >> 1848476

Severe chronic active Epstein-Barr virus infection syndrome.

M Okano1, S Matsumoto, T Osato, Y Sakiyama, G M Thiele, D T Purtilo.   

Abstract

Reports of unusually severe lymphoproliferative disorders associated with extremely high antibody titers against Epstein-Barr virus (EBV) have recently increased. The syndrome, which we designated severe chronic active EBV infection syndrome, is characterized by persistent or intermittent fever, lymphadenopathy, and hepatosplenomegaly and primarily affects children and young adults. Polyclonal gammopathy and bone marrow suppression are generally observed, and some patients develop B-cell or T-cell lymphoproliferation or lymphoma. Frequently, EBV genomes are detectable in tissues infiltrated with lymphoid cells. Additionally, it is difficult to establish spontaneous or B95-8 EBV-induced cell lines despite the expression of an activated EBV infection. We review and report here the published medical literature and our own experience regarding patients with severe chronic active EBV infection syndrome in an attempt to understand this enigmatic syndrome and the possible pathogenetic mechanism(s) responsible for this disorder.

Entities:  

Mesh:

Year:  1991        PMID: 1848476      PMCID: PMC358181          DOI: 10.1128/CMR.4.1.129

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  30 in total

1.  Chronic Epstein-Barr virus disease: a workshop held by the National Institute of Allergy and Infectious Diseases.

Authors:  M Tobi; S E Straus
Journal:  Ann Intern Med       Date:  1985-12       Impact factor: 25.391

2.  Successful treatment of chronic active Epstein-Barr virus infection with recombinant interleukin-2.

Authors:  K Kawa-Ha; E Franco; S Doi; K Yumura; S Ishihara; A Tawa; H Yabuuchi
Journal:  Lancet       Date:  1987-01-17       Impact factor: 79.321

3.  Selective lack of antibody to a component of EB nuclear antigen in patients with chronic active Epstein-Barr virus infection.

Authors:  G Miller; E Grogan; D Rowe; C Rooney; L Heston; R Eastman; W Andiman; J Niederman; G Lenoir; W Henle
Journal:  J Infect Dis       Date:  1987-07       Impact factor: 5.226

4.  Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection.

Authors:  W Henle; G Henle; J Andersson; I Ernberg; G Klein; C A Horwitz; G Marklund; L Rymo; C Wellinder; S E Straus
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

5.  Antibody responses to two Epstein-Barr virus nuclear antigens defined by gene transfer.

Authors:  G Miller; E Grogan; D K Fischer; J C Niederman; R T Schooley; W Henle; G Lenoir; C R Liu
Journal:  N Engl J Med       Date:  1985-03-21       Impact factor: 91.245

Review 6.  Epstein-Barr virus and human diseases: recent advances in diagnosis.

Authors:  M Okano; G M Thiele; J R Davis; H L Grierson; D T Purtilo
Journal:  Clin Microbiol Rev       Date:  1988-07       Impact factor: 26.132

7.  Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis.

Authors:  R J Risdall; R W McKenna; M E Nesbit; W Krivit; H H Balfour; R L Simmons; R D Brunning
Journal:  Cancer       Date:  1979-09       Impact factor: 6.860

8.  Brief report: killer cell defect and persistent immunological abnormalities in two patients with chronic active Epstein-Barr virus infection.

Authors:  J Joncas; Y Monczak; F Ghibu; C Alfieri; A Bonin; G Ahronheim; G Rivard
Journal:  J Med Virol       Date:  1989-06       Impact factor: 2.327

9.  T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections.

Authors:  J F Jones; S Shurin; C Abramowsky; R R Tubbs; C G Sciotto; R Wahl; J Sands; D Gottman; B Z Katz; J Sklar
Journal:  N Engl J Med       Date:  1988-03-24       Impact factor: 91.245

10.  Adenovirus type-2 in a patient with lethal hemorrhagic colonic ulcers and chronic active Epstein-Barr virus infection.

Authors:  M Okano; G M Thiele; J R Davis; W M Nauseef; F Mitros; D T Purtilo
Journal:  Ann Intern Med       Date:  1988-05       Impact factor: 25.391

View more
  26 in total

1.  Lymphoma Mimicking Chronic Active Epstein-Barr Virus: A Case Report.

Authors:  Rohini Bahethi; Mingyang Gray; Christian Salib; Ilya Likhterov
Journal:  Head Neck Pathol       Date:  2020-04-29

2.  Immediate-early transactivator Rta of Epstein-Barr virus (EBV) shows multiple epitopes recognized by EBV-specific cytotoxic T lymphocytes.

Authors:  S Pepperl; G Benninger-Döring; S Modrow; H Wolf; W Jilg
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

3.  Possible autoimmune hepatitis induced after chronic active Epstein-Barr virus infection.

Authors:  Yoshiko Wada; Chikako Sato; Kyoko Tomita; Rika Ishii-Aso; Hiroaki Haga; Kazuo Okumoto; Yuko Nishise; Hisayoshi Watanabe; Takafumi Saito; Yoshiyuki Ueno
Journal:  Clin J Gastroenterol       Date:  2013-11-23

Review 4.  X-linked lymphoproliferative disease (XLP) as a model of Epstein-Barr virus-induced immunopathology.

Authors:  D T Purtilo
Journal:  Springer Semin Immunopathol       Date:  1991

Review 5.  Progress and problems in understanding and managing primary Epstein-Barr virus infections.

Authors:  Oludare A Odumade; Kristin A Hogquist; Henry H Balfour
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

6.  Budd-Chiari syndrome and Epstein-Barr virus (EBV) associated plasmacytoma in a patient with chronic active EBV infection.

Authors:  S Nagafuchi; H Ishibashi; K Anzai; K Ohshima; Y Ohno; N Fukushima; M Hashizume; K Sugimachi; H Chuman; M Kikuchi
Journal:  Clin Investig       Date:  1994-11

7.  Intact antigen presentation for Epstein-Barr virus (EBV)-specific CTL by a lymphoblastoid cell line established from a patient with severe chronic active EBV infection.

Authors:  H Kimura; I Tsuge; S Imai; M Yamamoto; K Kuzushima; T Osato; T Morishima
Journal:  Med Microbiol Immunol       Date:  1995-08       Impact factor: 3.402

8.  Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay.

Authors:  H Kimura; M Morita; Y Yabuta; K Kuzushima; K Kato; S Kojima; T Matsuyama; T Morishima
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

9.  Chronic active Epstein-Barr virus infection associated with low expression of leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) on natural killer cells.

Authors:  Ala Aoukaty; I-Fang Lee; John Wu; Rusung Tan
Journal:  J Clin Immunol       Date:  2003-03       Impact factor: 8.317

10.  Severe chronic active EBV infection in an adult patient: case report.

Authors:  Sang-Yoon Ha; Chul-Won Chung; Young H Ko
Journal:  J Korean Med Sci       Date:  2004-06       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.